The European Commission was trying to be reassuring when it presented, on Thursday 4 April, the impact of a no-deal Brexit on the health sector. There will be no shortage of medicines, promises Vice-President Jyrki Katainen, who nevertheless stresses that the procedures for authorising medicines and medical devices will have to be adapted.
"A no-deal exit of the United Kingdom from the European Union will necessarily lead to changes in the health sector. The United Kingdom will no longer...